Brent R Carr, MD

My research integrates interventional psychiatry, neuropsychiatry, and the ethics of psychiatric treatment. I contribute to national efforts—such as the GenECT initiative and NNDC ketamine consensus work—that aim to identify biomarkers and clarify therapeutic boundaries in treatment-resistant depression. I also collaborate with neuromodulation developers on programming strategies for deep brain stimulation, including methods that support adaptive and responsive stimulation approaches.

In parallel with technical development, my work examines how psychiatric interventions are defined, evaluated, and justified—particularly how clinicians conceptualize response, nonresponse, agency, and risk in high-intensity care. Drawing on philosophy of psychiatry and neuroethics, I aim to strengthen the conceptual rigor and ethical clarity of psychiatric treatment, supporting more transparent decision-making and more precise, patient-centered outcomes.